What Is Mrna Used For
In 2018, the U.S. Food and Drug Administration approved one of the very first RNA-mechanism drugs. Its for hereditary transthyretin-mediated amyloidosis , which is a rare, but devastating genetic disorder that causes plaque to accumulate in the body.
Other genetic diseases cause similar buildup of similar kinds of plaque, with amyloid or amyloidosis in their names as well. And the mechanism is similar across many of these diseases.
Under normal circumstances, the liver produces a protein called transthyretin , which is used to transport vitamin A and a thyroid-binding protein in the body, the FDA explains. People with hATTR have a mutation in the gene for TTR, which means that the TTR protein manufactured by the liver is defective and unstable.
This is exactly where therapeutic RNA steps in. It effectively replaces a corrupt file in the DNA, and ensures the subsequent TTR proteins are less likely to be unstable and harm the body.
That sounds incredible, but of course, its also complicated. The FDA explains:
These drugs also require a delivery system such as a lipid nanoparticle to get the drug to specific target tissues. his carrier molecule can trigger its own immune response. Therefore, before taking , which is administered through an intravenous infusion, patients must take a steroid, acetaminophen, and antihistamines to decrease the chance of having immune reactions.
How Do Mrna Vaccines Differ From Traditional Vaccines
The goal of any vaccine is to train your body to recognize and fight germs by producing antibodies and activating immune cells.
Conventional vaccines introduce weakened, dead, or noninfectious parts of a virus or bacterium to the body. By contrast, mRNA vaccines give the body instructions for making its own viral or bacterial proteins, which the immune system then responds to.
The Next Big Thing In Synthetic Biology: Artificial Mrna And Gene Therapy
Although the messenger RNA and its roles in the cell were discovered more than half a century ago, it took more than four decades to consider its uses as biologics for human therapeutics. Nowadays, synthetic mRNA, produced in vitro by various enzymatic and non-enzymatic processes, is broadly used in vaccination, immunotherapeutics and even transient gene compensation.
Nevertheless, artificial mRNA synthesised in vitro and delivered exogenously suffers many limitations that hamper its potential. Firstly, even chemically modified exogenous RNA remains highly immunogenic due to its recognition by the Toll-Like Receptors on the external side of the endosomes and the cell membrane. Such innate immune activation induces an interferon response, which can be poorly tolerated and lead to serious adverse events. Secondly, mRNA is a fragile molecule, which is rapidly degraded in biological medium by abundant nucleases, making its uses in therapeutics difficult. Altogether, these limitations explain the difficulty in handling therapeutic mRNA, especially in cases of systemic administration for gene compensation. Therefore the development of novel alternatives is required.
Philippe Jais is the Co-Founder, President and Scientific Director of Eukarÿs, a French biotechnology company developing synthetic gene therapy and non-therapeutic products based on the C3P3 system.
Recommended Reading: What Is Figure Ground In Psychology
Messenger Rna Carries The Instructions For Making Proteins
mRNA is messenger RNA. mRNA is synthesized in the nucleus using the nucleotide sequence of DNA as a template. This process requires nucleotide triphosphates as substrates and is catalyzed by the enzyme RNA polymerase II. The process of making mRNA from DNA is called transcription, and it occurs in the nucleus. The mRNA directs the synthesis of proteins, which occurs in the cytoplasm. mRNA formed in the nucleus is transported out of the nucleus and into the cytoplasm where it attaches to the ribosomes. Proteins are assembled on the ribosomes using the mRNA nucleotide sequence as a guide. Thus mRNA carries a message from the nucleus to the cytoplasm. The message is encoded in the nucleotide sequence of the mRNA, which is complementary to the nucleotide sequence of the DNA that served as a template for synthesizing the mRNA. Making proteins from mRNA is called translation.
M. Holcik, in, 2017
Lnps As Delivery System
To overcome these transfection problems with naked mRNA, protecting delivery systems have been developed. Currently, the leading mRNA COVID-19 vaccines are all utilizing LNP technology. This illustrates the successes achieved with this type of nanoparticle to stabilize mRNA and successfully deliver it into cells . The LNPs in mRNA COVID-19 vaccines consist of four main components : a neutral phospholipid, cholesterol, a polyethylene-glycol -lipid, and an ionizable cationic lipid. The latter contains positively charged ionizable amine groups to interact with the anionic mRNA during particle formation and also facilitate membrane fusion during internalization . In addition, PEG-lipid is used to control the particle size and act as a steric barrier to prevent aggregation during storage. Together with the mRNA, these components form particles of about 60100 nm in size by using a rapid mixing production technique . The SARS-CoV-2 vaccine candidates nCoVsaRNA and ARCoV, for example, have average particle sizes of 75 nm and 89 nm, respectively .
Cryo-TEM image of mRNA-LNP showing bleb structures with distinctly different electron density. Adapted from
Schematic representation of the proposed models for siRNA-LNP and mRNA-LNP structure. A: multilamellar vesicles B: nanostructure core C: homogeneous core shell as discussed by
Recommended Reading: Holt Geometry Lesson 4.5 Practice B Answers
The Rise: Mrna As A Therapeutic Agent
The foundation of the concept of mRNA as a therapeutic agent was laid by Wolff J. and colleagues in 1990. The team injected naked RNA into mice muscles to provide proof of principle for direct gene transfer in vivo .
In 1992, a team of scientists working at Scripps Research Institute used mRNA to transiently reverse diabetes insipidus in Brattleboro rats that do not produce the hormone vasopressin .
Even though the concept of mRNA vaccines sounds relatively advanced, it dates back to 1995, when Robert and his team designed the first mRNA vaccine that encoded cancer antigens .
All this work in mRNA therapeutics laid the cornerstone of the first mRNA company ever founded: Merix Bioscience . In 2004, the company changed its name to Argos Therapeutics as a sign of its evolution.
How Does An Mrna Vaccine Work
Pfizer and Moderna are both working on COVID-19 vaccines using mRNA.
Scientists engineered a synthetic mRNA that codes for the spike protein on the coronavirus. This is the part of the virus that helps it enter human cells. The spikes are what you see on illustrations of the SARS-CoV-2 viral particle.
This synthetic mRNA instructs cells in the human body to make their own viral spike protein. This triggers the immune system to make antibodies to fight the virus. Once the immune system knows how to make these antibodies, it can do it again when exposed to the spike protein.
You can think of an mRNA vaccine as sending instructions into the body on how to fight COVID-19. Once the body makes the viral proteins, the immune system learns how to destroy them. This gives your body the tools to defend against SARS-CoV-2 if youre exposed.
Don’t Miss: What Is The Molecular Geometry Of Ccl4
The Central Dogma: Dna Encodes Rna Rna Encodes Protein
The central dogma: Instructions on DNA are transcribed onto messenger RNA. Ribosomes are able to read the genetic information inscribed on a strand of messenger RNA and use this information to string amino acids together into a protein.
The central dogma of molecular biology describes the flow of genetic information in cells from DNA to messenger RNA to protein. It states that genes specify the sequence of mRNA molecules, which in turn specify the sequence of proteins. Because the information stored in DNA is so central to cellular function, the cell keeps the DNA protected and copies it in the form of RNA. An enzyme adds one nucleotide to the mRNA strand for every nucleotide it reads in the DNA strand. The translation of this information to a protein is more complex because three mRNA nucleotides correspond to one amino acid in the polypeptide sequence.
What Is The Function Of Mrna
Without mRNA, your genetic code would never get used by your body. Messenger ribonucleuc acid, or mRNA for short, plays a vital role in human biology, specifically in a process known as protein synthesis. mRNA is a single-stranded molecule that carries genetic code from DNA in a cells nucleus to ribosomes, the cells protein-making machinery.
Read Also: People Who Are Always Late Psychology
A Closer Look At How Covid
COVID-19 mRNA vaccines give instructions for our cells to make a harmless piece of what is called the spike protein. The spike protein is found on the surface of the virus that causes COVID-19.
What Is Translation
The fundamental unit of a living thing is a cell. Similarly, it is commonly accepted that the molecular basis that serves as the fundamental unit of all living creatures is Deoxyribo-Nucleic Acid – DNA. DNA carries almost all of the information needed for an organism to carry out all of the biological, metabolic, and biophysical activities that occur throughout its life cycle.
Translation is defined in Molecular Biology as the process of turning nucleic acid information into amino acids. It also has something to do with the process of making proteins from mRNA templates.
During the translation process, the sequence of nucleotides on the RNA is translated into the amino acid sequence of proteins. Ribosomes carry out the entire translation procedure, where both ribosomes and tRNA dock on a matured mRNA transcript and choose various enzymes in an energy-intensive process that consumes both ATP and GTP.
Also Check: How To Do Elimination In Math
Why Rna At All
In the path from DNA to protein, RNA essentially serves as a middle-man, so why not eliminate the RNA go-between and move directly from DNA to protein? Simple life-forms, like DNA viruses, do just that, He said. Similarly, some of the most infamous viruses HIV, the common cold virus, influenza and COVID-19 stash all their genetic info in RNA, with no DNA predecessor.
More-complicated organisms need to do a lot more genetic regulation, however, He said. So, most of their genomes don’t code for proteins but code for parts of the genome that regulate other sequences. Promoters, for instance, can turn genes on or off. He said “you don’t want to convert 3 billion base pairs into protein sequence.” Expending cellular resources on so many sequences that don’t code for needed human proteins “would be a huge waste,” he said. RNA makes it possible to transcribe just the protein-coding bits of the genetic sequence into the mRNA intermediary.
Related: Genetics: The study of heredity
Additionally, mRNA provides a handy method of fine-tuning a gene’s output. “RNA is the DNA photocopy,” said the RNA Society, a nonprofit that facilitates sharing of RNA research. “When the cell needs to produce a certain protein, it produces multiple copies of that piece of DNA in the form of messenger RNA Thus, RNA expands the quantity of a given protein that can be made at one time.”
Each Trna Molecule Is Recognized By A Specific Aminoacyl
The ability of synthetases to recognize their correct cognatetRNAs is just as important to the accurate of the as- pairing. Once a tRNA is loaded with an ,codon-anticodon pairing directs the tRNA into the proper site if thewrong amino acid is attached to the tRNA, an error in synthesisresults.
As noted already, each synthetase can aminoacylate all thedifferent tRNAs whose anticodons correspond to the same . Therefore,all these cognate tRNAs must have a similar binding site, or identityelement, that is recognized by the synthetase. One approach forstudying the identity elements in tRNAs that are recognized by aminoacyl-tRNAsynthetases is to produce synthetic genes that encode tRNAs with normal andvarious mutant sequences by techniques discussed in Chapter 7. The normal and mutant tRNAs produced from suchsynthetic genes then can be tested for their ability to bind purifiedsynthetases.
Identity elements in tRNA involved in recognition byaminoacyl-tRNA synthetases, as demonstrated by both conservation andexperimentation. The 67 known tRNA sequences in E. coli were comparedby computer analysis. The conserved nucleotides in different
Recommended Reading: What Is The Molecular Geometry Of Ccl4
How Is Mrna Used In Covid
Everything that has been said here doesnt just apply to humans. Other organisms, including bacteria and viruses, also have DNA and/or RNA. The recent COVID-19 vaccines actually use mRNA from the virus itself in a rather sneaky way.
Usually, a vaccine uses a weakened or damaged version of a virus so that your body can have a practice run of fighting it. Your body will make antibodies that fight this weak form of the virus and thus will be able to recognize this same virus in the future and be able to quickly react to the real virus if ever exposed to it.
An mRNA vaccine works differently. Rather than inject a person with the actual virus, this type of vaccine instead injects the cells with some of the viruss mRNA. This mRNA contains instructions on how to build spike protein, meaning the protein that is found on the spiky surface of a virus. This protein is harmless and has no ill effects on the body.
So, your cells will begin making this harmless spike protein. Your immune system will then recognize that this spike protein doesnt belong in your body and make antibodies designed to destroy it. Making a long story short, this means your body will be able to recognize the spike proteins used by the actual virus. As a result, your immune system will immediately be able to make antibodies that swarm and kill the virus if it ever detects the spike protein in the body.
Using Mrna To Develop A New Category Of Medicines
At Moderna, we are leveraging the fundamental role that mRNA plays in protein synthesis. We have developed proprietary technologies and methods to create mRNA sequences that cells recognize as if they were produced in the body. We focus on diseases where enabling targeted cells to produce or turn on one or more given proteins will enable the body to fight or prevent a given disease.
- We start with our desired sequence for a protein.
- We design and synthesize the corresponding mRNA sequence the code that will create that protein.
- Before synthesis, we also engineer that mRNA sequence to optimize the mRNAs physical properties, as well as those of the encoded protein.
- We deliver the mRNA sequence to the cells responsible for making that protein via one of several modalities. Reaching different types of cells requires different delivery methods.
- And, once the mRNA the instructions are in the cell human biology takes over. Ribosomes read the code and build the protein, and the cells express the protein in the body.
Using mRNA as a drug opens up a breadth of opportunities to treat and prevent disease. mRNA medicines can go inside cells to direct protein production, something not possible with other drug approaches. We have the potential to treat or prevent diseases that today are not addressable potentially improving human health and impacting lives around the world.
Recommended Reading: Who Are Paris Jackson’s Biological Parents
Nonstandard Base Pairing Often Occurs Between Codons And Anticodons
If perfect Watson-Crick pairing were demanded between codons and anticodons,cells would have to contain exactly 61 different tRNA species, one for each that specifies an . As noted above, however, many cells containfewer than 61 tRNAs. The explanation for the smaller number lies in thecapability of a single tRNA to recognize more than one, but notnecessarily every, codon corresponding to a given amino acid. This broaderrecognition can occur because of nonstandard pairing between bases in theso-called wobble position: the third base in a mRNA codonand the corresponding first base in its tRNA anticodon. Although the first andsecond bases of a codon form standard Watson-Crick base pairs with the third andsecond bases of the corresponding anticodon, four nonstandard interactions canoccur between bases in the wobble position. Particularly important is theG·U , which structurally fits almost as well as the standardG·C pair. Thus, a given anticodon in tRNA with G in the first position can base-pair with the two corresponding codons that haveeither pyrimidine in the third position . For example, the phenylalanine codons UUUand UUC are both recognized by the tRNAthat has GAA as the anticodon. Infact, any two codons of the type NNPyr encode a single aminoacid and are decoded by a single tRNA with G in the first position ofthe anticodon.
Where Translation Occurs
Within all cells, the translation machinery resides within a specialized organelle called the ribosome. In eukaryotes, mature mRNA molecules must leave the nucleus and travel to the cytoplasm, where the ribosomes are located. On the other hand, in prokaryotic organisms, ribosomes can attach to mRNA while it is still being transcribed. In this situation, translation begins at the 5′ end of the mRNA while the 3′ end is still attached to DNA.
In all types of cells, the ribosome is composed of two subunits: the large subunit and the small subunit . Each subunit exists separately in the cytoplasm, but the two join together on the mRNA molecule. The ribosomal subunits contain proteins and specialized RNA moleculesspecifically, ribosomal RNA and transfer RNA . The tRNA molecules are adaptor moleculesthey have one end that can read the triplet code in the mRNA through complementary base-pairing, and another end that attaches to a specific amino acid . The idea that tRNA was an adaptor molecule was first proposed by Francis Crick, co-discoverer of DNA structure, who did much of the key work in deciphering the genetic code .
Within the ribosome, the mRNA and aminoacyl-tRNA complexes are held together closely, which facilitates base-pairing. The rRNA catalyzes the attachment of each new amino acid to the growing chain.
Recommended Reading: Algebra 1 Eoc Practice Test 2015